MedPath

Hyperactivity Assessment in Children With Attention-deficit Hyperactivity Disorder

Conditions
Attention Deficit Disorder With Hyperactivity
Interventions
Device: Garmin Vivosmart wearable device
Registration Number
NCT05810636
Lead Sponsor
National Taiwan University Hospital
Brief Summary

Attention-deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by inattention, hyperactivity, and impulsivity. Clinical diagnosis of this disorder depends of history taking, parent report, and questionnaire. Attention test such as continuous performance test can provide quantitative measurement on attention deficits; however, there is a lack of objective tool to quantify the activity level. This study aims to assess activity level in children with ADHD. We plan to recruit 50 children with ADHD and 50 neurotypical children. The activity level measured by wearable device will be compared between ADHD and neurotypical children. The correlation between behavior rating on questionnaire and quantitative data measured by wearable device will be analyzed.

Detailed Description

Not available

Recruitment & Eligibility

Status
ENROLLING_BY_INVITATION
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
ADHD groupGarmin Vivosmart wearable deviceInclusion criteria: * DSM-5 Attention-deficit hyperactivity disorder * 7\~18 years old * Willing to carry smartwatch and smartphone most of the time during one-month study period Exclusion criteria: - Comorbid with major psychiatric disorders (i.e., schizophrenia, bipolar disorder) or neurodevelopmental disorders (i.e., intellectual disability, autism spectrum disorder)
Neurotypical groupGarmin Vivosmart wearable deviceInclusion criteria: * 7\~18 years old without a diagnosis of Attention-deficit hyperactivity disorder * Willing to carry smartwatch and smartphone most of the time during one-month study period Exclusion criteria: * Have a diagnosis of major psychiatric disorders (i.e., schizophrenia, bipolar disorder) or neurodevelopmental disorders (i.e., intellectual disability, autism spectrum disorder) * Unable to use smartwatch and smartphone
Primary Outcome Measures
NameTimeMethod
Acceleration24 hours for 30 days

Arm Acceleration

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

National Taiwan University Hospital

🇨🇳

Taipei city, Taiwan

© Copyright 2025. All Rights Reserved by MedPath